Revolution Medicines, Inc. (RVMD)

NASDAQ: RVMD · Real-Time Price · USD

33.62

-1.74 (-4.92%)

Apr 1, 2025, 4:00 PM EDT - Market closed

Revolution Medicines Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2017
Period Ending	Apr '25 Apr 1, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2017
Market Capitalization	6,250	8,083	4,720	2,115	1,855	2,628	Upgrade
Market Cap Growth	71.26%	71.26%	123.15%	14.03%	-29.43%	-	Upgrade
Enterprise Value	4,097	6,620	3,969	1,525	1,278	2,195	Upgrade
Last Close Price	33.62	43.74	28.68	23.82	25.17	39.59	Upgrade
PS Ratio	-	407.58	59.78	63.11	61.14	Upgrade
PB Ratio	2.76	3.57	2.58	3.09	3.08	5.54	Upgrade
P/TBV Ratio	3.68	3.68	2.69	3.46	3.51	6.58	Upgrade
EV/Sales Ratio	-	342.78	43.11	43.48	51.07	Upgrade
Debt / Equity Ratio	0.06	0.06	0.05	0.09	0.11	0.07	Upgrade
Asset Turnover	-	-	0.01	0.05	0.05	0.11	Upgrade
Quick Ratio	13.97	13.97	12.89	10.48	9.66	9.48	Upgrade
Current Ratio	14.20	14.20	13.06	10.65	9.77	9.63	Upgrade
Return on Equity (ROE)	-29.33%	-29.33%	-34.75%	-38.63%	-34.73%	-34.49%	Upgrade
Return on Assets (ROA)	-18.66%	-18.66%	-20.08%	-20.83%	-18.00%	-17.56%	Upgrade
Return on Capital (ROIC)	-19.97%	-19.97%	-21.67%	-22.76%	-19.98%	-20.96%	Upgrade
Earnings Yield	-9.60%	-7.42%	-9.25%	-11.76%	-10.09%	-4.12%	Upgrade
FCF Yield	-9.08%	-7.02%	-7.59%	-11.12%	-8.29%	-3.92%	Upgrade
Buyback Yield / Dilution	-48.24%	-48.24%	-40.34%	-10.74%	-32.68%	-1879.16%	Upgrade

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q